155 related articles for article (PubMed ID: 11388746)
1. Importance of CD34+ cell subsets in autologous PBSC transplantation: the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment.
Hénon PH; Sovalat H; Bourderont D
J Biol Regul Homeost Agents; 2001; 15(1):62-7. PubMed ID: 11388746
[TBL] [Abstract][Full Text] [Related]
2. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
[TBL] [Abstract][Full Text] [Related]
3. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
Meldgaard Knudsen L; Jensen L; Jarlbaek L; Hansen PG; Hansen SW; Drivsholm L; Nikolaisen K; Gaarsdal E; Johnsen HE
Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
[TBL] [Abstract][Full Text] [Related]
4. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation.
Payne TA; Traycoff CM; Laver J; Xu F; Srour EF; Abboud MR
Bone Marrow Transplant; 1995 Feb; 15(2):187-92. PubMed ID: 7539665
[TBL] [Abstract][Full Text] [Related]
6. Stem cell enumeration in cord blood vs bone marrow and peripheral blood.
Bertolini F; Battaglia M; Lanza A; Gibelli N; Palermo B; Pavesi L; Robustelli della Cuna G
Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S57. PubMed ID: 9715890
[TBL] [Abstract][Full Text] [Related]
7. CD34+ cell dose and CD33- subsets: collection and engraftment kinetics in autologous peripheral blood stem cells transplantation.
Sampol Mayol A; Besalduch Vital J; Galmés Llodrá A; Bargay Lleonart J; Matamoros Flori N; Morey Sureda M; Novo García A; Mascaró Riera M; Gonzaléz Bach E; Martínez García P
Haematologica; 1998 Jun; 83(6):489-95. PubMed ID: 9676020
[TBL] [Abstract][Full Text] [Related]
8. Characterization of peripheral blood progenitor cells mobilized by nartograstim (N-terminal replaced granulocyte colony-stimulating factor) in normal volunteers.
Maruyama K; Tsuji K; Tanaka R; Yamada K; Kodera Y; Nakahata T
Bone Marrow Transplant; 1998 Aug; 22(4):313-20. PubMed ID: 9722064
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P
Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022
[TBL] [Abstract][Full Text] [Related]
10. [Kinetics of hematopoiesis after high-dose chemotherapy and autologous peripheral stem cell transplantation].
Mayer J; Korístek Z; Pospísil Z; Vásová I; Adam Z; Hájek R; Krejcí M; Král Z; Navrátil M; Vorlícek J; Bourková L; Matýsková M; Adler J; Vinklárková J; Klabusay M; Koutná I; Hoffová V; Schmitzová D; Janovská E
Cas Lek Cesk; 1999 Mar; 138(6):170-7. PubMed ID: 10510531
[TBL] [Abstract][Full Text] [Related]
11. Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+)38(-), and week-6 CAFC assays predict poor engraftment.
Robinson SN; Freedman AS; Neuberg DS; Nadler LM; Mauch PM
Exp Hematol; 2000 Dec; 28(12):1325-33. PubMed ID: 11146154
[TBL] [Abstract][Full Text] [Related]
12. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts.
Theilgaard-Mönch K; Raaschou-Jensen K; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E
Bone Marrow Transplant; 2003 Dec; 32(12):1125-33. PubMed ID: 14647266
[TBL] [Abstract][Full Text] [Related]
13. Comparison of processing four and five times the patients' blood volume during peripheral blood stem cell collection and analysis of CD34+38--and CD34+49d+ subsets during apheresis.
Bojko P; Scharifi M; Stössel K; Seeber S
J Cancer Res Clin Oncol; 2002 Jan; 128(1):19-28. PubMed ID: 11862468
[TBL] [Abstract][Full Text] [Related]
14. CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation.
Zubair AC; Kao G; Daley H; Schott D; Freedman A; Ritz J
Cytotherapy; 2006; 8(4):399-407. PubMed ID: 16923616
[TBL] [Abstract][Full Text] [Related]
15. Primordial role of CD34+ 38- cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation.
Hénon P; Sovalat H; Becker M; Arkam Y; Ojeda-Uribe M; Raidot JP; Husseini F; Wunder E; Bourderont D; Audhuy B
Br J Haematol; 1998 Nov; 103(2):568-81. PubMed ID: 9827938
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a population of cells in the bone marrow that phenotypically mimics hematopoietic stem cells: resting stem cells or mystery population?
Randall TD; Weissman IL
Stem Cells; 1998; 16(1):38-48. PubMed ID: 9474746
[TBL] [Abstract][Full Text] [Related]
17. Cell adhesion molecules in cord blood hematopoietic progenitors.
Timeus F; Crescenzio N; Marranca D; Dall'Aglio M; Fazio L; Di Marco M; Saracco P; Ricotti M; Gabutti V
Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S61-2. PubMed ID: 9715892
[TBL] [Abstract][Full Text] [Related]
18. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.
Allan DS; Keeney M; Howson-Jan K; Popma J; Weir K; Bhatia M; Sutherland DR; Chin-Yee IH
Bone Marrow Transplant; 2002 Jun; 29(12):967-72. PubMed ID: 12098064
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
20. Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy.
Li K; Li CK; Chuen CK; Tsang KS; Fok TF; James AE; Lee SM; Shing MM; Chik KW; Yuen PM
Eur J Haematol; 2005 Feb; 74(2):128-35. PubMed ID: 15654904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
